Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $591.32 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $128.90 | 8 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $120.00 | 4 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $52.25 | 4 | $0 (2022) |
| Dexcom, Inc. | $44.47 | 3 | $0 (2024) |
| Abbott Laboratories | $38.10 | 2 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.15 | 2 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $25.17 | 2 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $19.49 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $17.86 | 1 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $17.28 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.41 | 2 | Averitas Pharma Inc. ($16.15) |
| 2023 | $79.24 | 5 | Neurocrine Biosciences, Inc. ($19.49) |
| 2022 | $289.86 | 15 | E.R. Squibb & Sons, L.L.C. ($104.75) |
| 2021 | $190.81 | 13 | AbbVie Inc. ($60.49) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Endocrinology | ||||||
| 03/20/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/25/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PSYCHIATRY | ||||||
| 06/22/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: INSOMNIA | ||||||
| 05/30/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Neuropsychiatry | ||||||
| 04/25/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 04/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Endocrinology | ||||||
| 10/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Endocrinology | ||||||
| 08/31/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Gastroenterology | ||||||
| 08/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardio-renal | ||||||
| 06/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Cardio-renal | ||||||
| 05/11/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Gastroenterology | ||||||
| 03/29/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $56.32 | General |
| Category: Cardiovascular | ||||||
| 03/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: RESPIRATORY | ||||||
| 03/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.65 | General |
| Category: Cardiovascular | ||||||
| 03/01/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes Care | ||||||
| 01/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $35.78 | General |
| Category: Cardiovascular | ||||||
| 01/12/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Diabetes Care | ||||||
| 11/17/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 744 | 1,171 | $160,758 | $54,958 |
| 2022 | 13 | 928 | 1,452 | $178,373 | $59,718 |
| 2021 | 15 | 1,074 | 1,773 | $213,734 | $74,567 |
| 2020 | 19 | 1,178 | 2,240 | $269,890 | $81,740 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 188 | 381 | $56,769 | $18,905 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 153 | $31,212 | $11,030 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 102 | 102 | $26,010 | $10,988 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 175 | 287 | $31,570 | $8,626 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 17 | $4,624 | $2,023 | 43.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 34 | $4,985 | $1,588 | 31.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 14 | $2,808 | $896.40 | 31.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 58 | $2,030 | $474.61 | 23.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 69 | 125 | $750.00 | $426.25 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 219 | 388 | $57,812 | $18,299 | 31.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 216 | 410 | $45,100 | $13,024 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $24,225 | $10,365 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 134 | $27,336 | $9,072 | 33.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 51 | 60 | $8,400 | $2,654 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 18 | $4,896 | $2,159 | 44.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $4,575 | $2,088 | 45.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 109 | 199 | $1,194 | $671.83 | 56.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 15 | 30 | $840.00 | $489.90 | 58.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 53 | $1,855 | $376.76 | 20.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 15 | 17 | $391.00 | $277.71 | 71.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 17 | 19 | $1,539 | $180.54 | 11.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 14 | 14 | $210.00 | $60.25 | 28.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 256 | 493 | $73,457 | $24,843 | 33.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 208 | 395 | $43,450 | $12,887 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 133 | 169 | $34,476 | $12,159 | 35.3% |
About Jody Stark, NP
Jody Stark, NP is a Psychiatric/Mental Health healthcare provider based in Ontario, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851472989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jody Stark, NP has received a total of $591.32 in payments from pharmaceutical and medical device companies, with $31.41 received in 2024. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($591.32).
As a Medicare-enrolled provider, Stark has provided services to 3,924 Medicare beneficiaries, totaling 6,636 services with total Medicare billing of $270,983. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Family
- Location Ontario, OR
- Active Since 10/17/2006
- Last Updated 10/19/2022
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1851472989
Products in Payments
- ELIQUIS (Drug) $120.00
- UBRELVY (Drug) $74.46
- XIFAXAN (Drug) $52.25
- Dexcom G6 Transmitter (Medical Supply) $44.47
- QULIPTA (Drug) $36.75
- Kerendia (Drug) $25.17
- ARALAST (Biological) $22.10
- INGREZZA (Drug) $19.49
- FREESTYLE LIBRE 2 (Device) $19.45
- FreeStyle Libre 2 (Device) $18.65
- REXULTI (Drug) $17.86
- VRAYLAR (Drug) $17.69
- QUVIVIQ (Drug) $17.28
- MOUNJARO (Drug) $17.03
- QUTENZA (Drug) $16.15
- STIOLTO RESPIMAT (Drug) $16.14
- GLASSIA (Biological) $13.05
- BELBUCA (Drug) $12.96
- LATUDA (Drug) $11.63
- SOLIQUA 100/33 (Biological) $11.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Ontario
Tameka Dyce, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $3,779
Ms. Stacey Carabin, Aprn-Cnp, Pmhnp-Bc, APRN-CNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $383.99
Mrs. Lindsay Wood, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $365.49
Meena Kakar, Np, NP
Psychiatric/Mental Health — Payments: $92.26
Tami Lamb, Np, NP
Psychiatric/Mental Health — Payments: $60.24
Patricia Barfield, Aprn-Bc Pmhnp, APRN-BC PMHNP
Psychiatric/Mental Health